• Source:JND
Add as a preferred

Emcure Pharma IPO Subscription Status:  The initial public offering (IPO) of Emcure Pharmaceuticals received 4.98 times the bid against its issue size till 5:00 pm on the second day of bidding i.e. Thursday. The Bain capital-backed Emcure Pharma public issue is attracting investors' attention it was fully subscribed on the very first day of bidding.

The quota reserved for Non-Institutional Investors (NII) subscribed 13.67 times, retail investors quota received 3.43 times bid while the quota reserved for the company's employees got 4.83 times subscription.

Price range and lot size of Emcure Pharma IPO

The company has announced the price range at rs Rs 960-1008 per share with a face value of Rs 10. An investor has to buy a lot of 14 equity shares to bid for the IPO which means a minimum investment of Rs 13440. Retail investors are allowed to invest a maximum amount of up to Rs 2 lacs.

Also Read: Stock Market: Sensex, Nifty Close At Record Highs On Buying In ICICI Bank, Infosys, TCS

Discount for employees

Employees of Emcure Pharmaceuticals have been showing huge interest in bidding as the category reserved for them has been subscribed over 4.83 times. The company has also announced a special discount of 90 rupees for eligible employees. The employees can invest up to Rs 50000.

Book-running lead Managers for the IPO are Axis Capital Limited, Kotak Mahindra Capital Company, Jefferies India Private Limited, and J.P. Morgan India Private Limited

Emcure Pharma GMP

According to Investorgain, the shares of Emcure Pharma are trading with a premium of 33.73 percent in the grey market. The upper band of the price range is Ra 1008 per share, while the shares are trading at Rs 1,348 per share, up Rs 340 or 33.73 percent. If the grey market predictions hold then investors may make over 30 percent gain on listing day.

Also Read: SBI Launches 11 New Initiatives To Enhance Digital Banking Features, Reduce Risks In Farm Loan Portfolio